VerifiedBiotechnology Research· Founded 2013

Neuro-Bio Ltd

Neuro-Bio has discovered a novel 14 amino acid bioactive peptide (T14) derived from the C terminus of AChE. T14 is neurotoxic in the adult brain and published data shows it to be a potential key driver of neurodegeneration. This new distinct mechanism is being exploited by Neuro-Bio to discover first-in-class drugs to treat Alzheimer's disease and to develop a biomarker as a companion diagnostic’.

7-day free trial · no credit card

Oxford, United Kingdom25(11 to 50)$1M to <$10M2013neuro-bio.com LinkedIn

Verified contacts

22

available on Kipplo

LinkedIn employees

25

11 to 50 range

Open roles

—

no listings

Distinct roles

17

indexed titles

Tech stack

0

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 22 verified contacts at Neuro-Bio Ltd

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

22 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 22 verified contacts

Top roles at Neuro-Bio Ltd

17 distinct titles indexed · top 10 shown.

3senior scientist
2junior scientist
2office manager
2operations manager
1',
1administrative analyst
1business development manager
1chief scientific officer
1diagnostic lead scientist
1finance assistant
+7more titles

Sign up to unlock all 22 contacts at Neuro-Bio Ltd

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 22 verified contacts at Neuro-Bio Ltd

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Neuro-Bio Ltd | Kipplo Discover